BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bauditz J, Lochs H. Angiogenesis and vascular malformations: antiangiogenic drugs for treatment of gastrointestinal bleeding. World J Gastroenterol 2007;13:5979-84. [PMID: 18023086 DOI: 10.3748/wjg.v13.45.5979] [Cited by in Crossref: 22] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Lebrin F, Srun S, Raymond K, Martin S, van den Brink S, Freitas C, Bréant C, Mathivet T, Larrivée B, Thomas JL. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med. 2010;16:420-428. [PMID: 20364125 DOI: 10.1038/nm.2131] [Cited by in Crossref: 222] [Cited by in F6Publishing: 198] [Article Influence: 18.5] [Reference Citation Analysis]
2 Baptista V, Marya N, Singh A, Rupawala A, Gondal B, Cave D. Continuing challenges in the diagnosis and management of obscure gastrointestinal bleeding. World J Gastrointest Pathophysiol 2014; 5(4): 523-533 [PMID: 25400996 DOI: 10.4291/wjgp.v5.i4.523] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
3 Amanzada A, Töppler GJ, Cameron S, Schwörer H, Ramadori G. A case report of a patient with hereditary hemorrhagic telangiectasia treated successively with thalidomide and bevacizumab. Case Rep Oncol. 2010;3:463-470. [PMID: 21611144 DOI: 10.1159/000323152] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
4 Liu MM, Chen XH, Lu XM, Wang FF, Wang C, Liu Y, Li PL, Du BT, Liang S, Gong PD, Wang YX. Variations in the Profiles of Vascular-Related Factors Among Different Sub-Types of Polycystic Ovarian Syndrome in Northern China. Front Endocrinol (Lausanne) 2020;11:527592. [PMID: 33716949 DOI: 10.3389/fendo.2020.527592] [Reference Citation Analysis]
5 Lee BL, Turner J, Hurley J, Green J, Hawkes N, Alcolado R. Two for the price of one: a dual treatment benefit of long-acting octreotide in occult bleeding and diuretic intractable ascites. Frontline Gastroenterol 2011;2:226-9. [PMID: 28839614 DOI: 10.1136/fg.2010.003459] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Meurer SK, Alsamman M, Scholten D, Weiskirchen R. Endoglin in liver fibrogenesis: Bridging basic science and clinical practice. World J Biol Chem 2014; 5(2): 180-203 [PMID: 24921008 DOI: 10.4331/wjbc.v5.i2.180] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
7 Peng M, Guo X, Yi F, Romeiro FG, Mancuso A, Qi X. Pharmacotherapy for the Treatment of Gastric Antral Vascular Ectasia: A Narrative Review. Adv Ther 2021;38:5065-77. [PMID: 34524644 DOI: 10.1007/s12325-021-01912-6] [Reference Citation Analysis]
8 Thomas W, Warner E, Cameron E, Symington E. Successful treatment of acquired von Willebrand disease with lenalidomide leading to dramatic resolution of intractable gastrointestinal bleeding: A case report. Haemophilia 2018;24:e140-2. [DOI: 10.1111/hae.13464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
9 Kim W, Yee J, Chang BC, Chung JE, Lee KE, Gwak HS. TGF-β1 polymorphism increases the risk of bleeding complications in patients on oral anticoagulant after cardiac valve replacement. Heart Vessels 2021. [PMID: 33983456 DOI: 10.1007/s00380-021-01867-2] [Reference Citation Analysis]
10 Yee J, Kim W, Chang BC, Chung JE, Lee KE, Gwak HS. Association between VEGFA gene polymorphisms and bleeding complications in patients maintaining therapeutic international normalized ratio. Pharmacogenomics 2019;20:659-67. [PMID: 31068094 DOI: 10.2217/pgs-2019-0005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Khatri NV, Patel B, Kohli DR, Solomon SS, Bull-Henry K, Kessler CM. Lenalidomide as a novel therapy for gastrointestinal angiodysplasia in von Willebrand disease. Haemophilia 2018;24:278-82. [PMID: 29446520 DOI: 10.1111/hae.13419] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
12 Starke RD, Ferraro F, Paschalaki KE, Dryden NH, McKinnon TA, Sutton RE, Payne EM, Haskard DO, Hughes AD, Cutler DF, Laffan MA, Randi AM. Endothelial von Willebrand factor regulates angiogenesis. Blood 2011;117:1071-80. [PMID: 21048155 DOI: 10.1182/blood-2010-01-264507] [Cited by in Crossref: 272] [Cited by in F6Publishing: 258] [Article Influence: 22.7] [Reference Citation Analysis]
13 Pardali E, Ten Dijke P. TGFβ signaling and cardiovascular diseases. Int J Biol Sci 2012;8:195-213. [PMID: 22253564 DOI: 10.7150/ijbs.3805] [Cited by in Crossref: 6] [Cited by in F6Publishing: 66] [Article Influence: 0.6] [Reference Citation Analysis]
14 Yee J, Kim W, Chang BC, Chung JE, Lee KE, Gwak HS. Genetic variations in the transcription factors GATA4 and GATA6 and bleeding complications in patients receiving warfarin therapy. Drug Des Devel Ther 2019;13:1717-27. [PMID: 31190750 DOI: 10.2147/DDDT.S198018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Lobeek D, Bouwman FCM, Aarntzen EHJG, Molkenboer-Kuenen JDM, Flucke UE, Nguyen HL, Vikkula M, Boon LM, Klein W, Laverman P, Oyen WJG, Boerman OC, Terry SYA, Schultze Kool LJ, Rijpkema M. A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using 68Ga-RGD PET/CT. J Nucl Med 2020;61:270-5. [PMID: 31519800 DOI: 10.2967/jnumed.119.231167] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Sewduth RN, Pandolfi S, Steklov M, Sheryazdanova A, Zhao P, Criem N, Baietti MF, Lechat B, Quarck R, Impens F, Sablina AA. The Noonan Syndrome Gene Lztr1 Controls Cardiovascular Function by Regulating Vesicular Trafficking. Circ Res 2020;126:1379-93. [PMID: 32175818 DOI: 10.1161/CIRCRESAHA.119.315730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Kim W, Yee J, Chang BC, Chung JE, Lee KE, Gwak HS. Association between HNF4A mutations and bleeding complications in patients with stable international normalized ratio. Pharmacogenet Genomics 2019;29:200-6. [PMID: 31461081 DOI: 10.1097/FPC.0000000000000384] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Holleran G, McNamara D. An overview of angiodysplasia: Management and patient prospects. Expert Rev Gastroenterol Hepatol. 2018;12:863-872. [PMID: 30028221 DOI: 10.1080/17474124.2018.1503532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 Morrell NW, Bloch DB, ten Dijke P, Goumans MJ, Hata A, Smith J, Yu PB, Bloch KD. Targeting BMP signalling in cardiovascular disease and anaemia. Nat Rev Cardiol 2016;13:106-20. [PMID: 26461965 DOI: 10.1038/nrcardio.2015.156] [Cited by in Crossref: 115] [Cited by in F6Publishing: 105] [Article Influence: 16.4] [Reference Citation Analysis]
20 Bowcock SJ, Patrick HE. Lenalidomide to control gastrointestinal bleeding in hereditary haemorrhagic telangiectasia: potential implications for angiodysplasias? Br J Haematol. 2009;146:220-222. [PMID: 19438503 DOI: 10.1111/j.1365-2141.2009.07730.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
21 Yee J, Kim W, Chang BC, Chung JE, Lee KE, Gwak HS. Effects of Polymorphisms in Myc-Related Genes on Bleeding Complications in Patients with Stable Warfarin Responses. Cardiovasc Ther 2019;2019:1813747. [PMID: 31772606 DOI: 10.1155/2019/1813747] [Reference Citation Analysis]
22 Martins NB, Chaput KJ, Stawicki SP, Modi R. Octreotide as an adjunct in the management of arterial gastrointestinal bleeding: Should it be considered in refractory cases of obscure origin? Int J Crit Illn Inj Sci 2017;7:8-11. [PMID: 28382252 DOI: 10.4103/IJCIIS.IJCIIS_14_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
23 Saeed F, Agrawal N, Greenberg E, Holley JL. Lower gastrointestinal bleeding in chronic hemodialysis patients. Int J Nephrol 2011;2011:272535. [PMID: 22007297 DOI: 10.4061/2011/272535] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
24 Romagnuolo J, Brock AS, Ranney N. Is Endoscopic Therapy Effective for Angioectasia in Obscure Gastrointestinal Bleeding?: A Systematic Review of the Literature. J Clin Gastroenterol. 2015;49:823-830. [PMID: 25518005 DOI: 10.1097/mcg.0000000000000266] [Cited by in Crossref: 39] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
25 Zakka FR, Chang PY, Giuliari GP, Foster CS. Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease. Clin Ophthalmol 2009;3:567-79. [PMID: 19898629 DOI: 10.2147/opth.s4445] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
26 Yen MH, Chen CN. Surgical treatment of gastrointestinal hereditary hemorrhagic telangiectasia. Acute Med Surg 2016;3:207-9. [PMID: 29123785 DOI: 10.1002/ams2.158] [Reference Citation Analysis]
27 Di Pietro M, Pascuali N, Parborell F, Abramovich D. Ovarian angiogenesis in polycystic ovary syndrome. Reproduction 2018;155:R199-209. [PMID: 29386378 DOI: 10.1530/REP-17-0597] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
28 Lourdes Ruiz Rebollo M, Barrio Andrés J, Fernández-orcajo P, Prada Lobato J, Mena Martín FJ, Velicia Llames R, Caro-paton A. Octreótida en el sangrado por angiodisplasias intestinales. Gastroenterología y Hepatología 2008;31:713-4. [DOI: 10.1016/s0210-5705(08)75826-6] [Reference Citation Analysis]
29 Horiuchi H, Doman T, Kokame K, Saiki Y, Matsumoto M. Acquired von Willebrand Syndrome Associated with Cardiovascular Diseases. J Atheroscler Thromb 2019;26:303-14. [PMID: 30867356 DOI: 10.5551/jat.RV17031] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
30 Al Asoom LI. Coronary angiogenic effect of long-term administration of Nigella sativa. BMC Complement Altern Med 2017;17:308. [PMID: 28610577 DOI: 10.1186/s12906-017-1795-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
31 Almadi M, Ghali PM, Constantin A, Galipeau J, Szilagyi A. Recurrent obscure gastrointestinal bleeding: dilemmas and success with pharmacological therapies. Case series and review. Can J Gastroenterol 2009;23:625-31. [PMID: 19816627 DOI: 10.1155/2009/862816] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
32 McFarlane M, O'Flynn L, Ventre R, Disney BR. Emerging role of thalidomide in the treatment of gastrointestinal bleeding. Frontline Gastroenterol 2018;9:98-104. [PMID: 29588836 DOI: 10.1136/flgastro-2017-100870] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
33 Macdonald J, Porter V, Scott NW, McNamara D. Small bowel lymphangiectasia and angiodysplasia: a positive association; novel clinical marker or shared pathophysiology? J Clin Gastroenterol 2010;44:610-4. [PMID: 20535025 DOI: 10.1097/MCG.0b013e3181dd9c3f] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
34 Abramovich D, Irusta G, Bas D, Cataldi NI, Parborell F, Tesone M. Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome. Endocrinology 2012;153:3446-56. [PMID: 22577112 DOI: 10.1210/en.2012-1105] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
35 Alam MA, Sami S, Babu S. Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide. BMJ Case Rep 2011;2011:bcr0820114585. [PMID: 22674103 DOI: 10.1136/bcr.08.2011.4585] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]